Triptorelin Pamoate (Trelstar®)

Common name: Triptorelin Pamoate
Brand name: Trelstar®
 

What is Triptorelin Pamoate?

Triptorelin is used in the palliative treatment of hormone dependent advanced prostate cancer. It works by reducing the amount testosterone in the blood.
 

How is Triptorelin Pamoate administered?

Triptorelin Pamoate is administered by intramuscular injection.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received triptorelin pamoate. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Breast enlargement
  • Constipation
  • Diarrhea
  • Difficulty sleeping
  • Fatigue / weakness
  • Headaches
  • Hot flashes
  • Impotence (erectile dysfunction)
  • Nausea
  • Reduced libido (low sex drive)

 
Is Triptorelin Pamoate covered in my province or territory?

Triptorelin pamoate is covered by provincial drug programs in:
  • New Brunswick
  • Newfoundland & Labrador
  • Northwest Territories
  • Nova Scotia
  • Nunavut
  • Ontario
  • Quebec
  • Prince Edward Island
  • Yukon
Triptorelin pamoate is not covered by provincial drug programs in:
  • Alberta
  • British Columbia
  • Manitoba
  • Saskatchewan
 
Last Reviewed: November 2013

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive